ArticleUltrasonics sonochemistry2025
Ultrasound-Assisted green extraction and resin purification of Hypaphorine from Nanhaia speciosa using deep eutectic solvents.
Article in Ultrasonics sonochemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Phytochemical Profiling andFoods (Basel, Switzerland) · 2026Article
- Novel green solvent-in situ ultrasound synergistic extraction of phenolic acids from Lonicera japonica thunb.Ultrasonics sonochemistry · 2026Article
- Ultrasound-assisted temperature-responsive deep eutectic solvents for simultaneous extraction and separation of the alkaloid components from the white pepper.Ultrasonics sonochemistry · 2026Article
- Optimization of deep eutectic solvent extraction ofFrontiers in pharmacology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hypaphorine (HYP), a tryptophan-derived alkaloid with diverse pharmacological activities, was efficiently extracted from Nanhaia speciosa using a green and sustainable approach integrating ultrasound-assisted extraction (UAE), deep eutectic solvents (DESs), and macroporous resin (MAR) purification. The ultrasound-assisted DES extraction process was systematically optimized, with the best conditions identified as a lactic acid-fructose (1:1, mol/mol) DES containing 40 % water, an extraction temperature of 80 °C, a duration of 40 min, and a solid-to-liquid ratio of 1:20 g/mL. Under these conditions, the HYP yield reached 3.15 mg/g, representing improvements of 105.19 % and 70.62 % compared with conventional water and ethanol extraction, respectively, and 52.17 % higher than microwave-assisted extraction (MAE). To enhance purity, the crude extract was further purified using DM132 macroporous resin under optimized conditions (50 % ethanol eluent, 2.5 BV/h flow rate, column height-to-diameter ratio of 21:1, and elution volume of 4 BV), achieving a recovery rate of 89.53 % and a final purity of 79.57 %. DES recycling retained 94.21 % of the extraction efficiency after one reuse cycle. SEM analysis revealed significant disruption of the plant cell structure post-ultrasound-DES treatment. FTIR and DFT studies demonstrated strong hydrogen bonding and favorable binding energies between DES components and HYP, elucidating the extraction mechanism. This UAE-DES-MAR system not only enhanced the extraction and purification efficiency of HYP but also presented a green, recyclable, and scalable approach, offering promising applications for the sustainable industrial production of high-value alkaloids.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.